Alcoholic Hepatitis Syndrome: Prognosis and Course

  • Harold O. Conn
  • R. Hallak


The alcoholic hepatitis syndrome is a disease that is relatively easy to define for groups of patients. It is much more difficult to define for individual patients. This acute disorder of the liver is characterized by a history of excessive alcohol intake, by jaundice and hepatomegaly, and by laboratory abnormalities that include increased serum aminotransferase and alkaline phosphatase activity and leukocytosis composed largely of neutrophils. Prolongation of prothrombin time is common. Fever, ascites, and splenomegaly are often present. Abdnominal pain and anorexia occur frequently.


Serum Bilirubin Alcoholic Liver Disease Total Serum Bilirubin Alcoholic Hepatitis Serum Bilirubin Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rankin JGD, Orrego-Matte H, Deschenes J, et al: Alcoholic liver disease: The problem of diagnosis. Alcoholism: Clin Exp Res 2:327–328, 1978.CrossRefGoogle Scholar
  2. 2.
    Kryger S, Schlichting O, Dietrichson O, et al: The accuracy of the clinical diagnosis in acute hepatitis and alcoholic liver disease. Clinical versus morphological diagnosis. Scand J Gastroenterol 18:691–696, 1983.PubMedCrossRefGoogle Scholar
  3. 3.
    Poynard T, Degott C, Munoz C, et al: Relationship between degree of portal hypertension and liver histologic lesions in patients with alcoholic cirrhosis. Effect of acute alcoholic hepatitis on portal hypertension. Dig Dis Sci 32:337–343, 1987.PubMedCrossRefGoogle Scholar
  4. 4.
    Helman RA, Temko SS, Nye SW, et al: Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy. Ann Intern Med 74:311–321, 1987.Google Scholar
  5. 5.
    Conn HO, Blei AT, Chojkier M, et al: The naked physician: The blind interpretation of liver function tests in the differential diagnosis of jaundice, in Preisig R, Bircher J (eds): The Liver: Quantitative Aspects of Structure and Function. Third International Gstaad Symposium, Gstaad, 1978, pp. 386–394.Google Scholar
  6. 6.
    Morris JS, Gallo GA, Scheuer PJ, et al: Percutaneous liver biopsy in patients with large bile duct obstruction. Gastroenterology 68:750–754, 1975.PubMedGoogle Scholar
  7. 7.
    Morgan MY, Sherlock S: Sex-related differences among 100 patients with alcoholic liver disease. Br Med J 1:939–941, 1977.PubMedCrossRefGoogle Scholar
  8. 8.
    Orrego H, Blendis LM, Crossley IR, et al: Correlation of intrahepatic pressure with collagen in the Disse space and hepatomegaly in humans and in the rat. Gastroenterology 80:546–556, 1981.PubMedGoogle Scholar
  9. 9.
    Skrainka B, Stahlhut J, Fulbeck CL, et al: Measuring liver span. Bedside examination versus ultrasound and scintiscan. J Clin Gastroenterol 8:267–270, 1986.PubMedCrossRefGoogle Scholar
  10. 10.
    Espinoza P, Ducot B, Pelletier G, et al: Interobserver agreement in the physical diagnosis of alcoholic liver disease. Dig Dis Sci 32:244–247, 1987.PubMedCrossRefGoogle Scholar
  11. 11.
    Rasmussen SN: Liver volume by ultrasonic scanning. Br J Radiol 45:579, 1972.PubMedCrossRefGoogle Scholar
  12. 12.
    Weiss JS, Gautam A, Lauff JJ, et al: The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia. S Engl J Med 309:147–150, 1983.CrossRefGoogle Scholar
  13. 13.
    Sanchez-Tapias JM, Fiol B, Rodes J: (+)-Cyanidanol-3 in mild alcoholic hepatitis, in Conn HO (ed): International Workshop on (+)-Cyanidanol-3 in Diseases of the Liver. Royal Society of Medicine, Academic Press, London and Grune and Stratton, New York, 1981, pp. 173–175.Google Scholar
  14. 14.
    Palmas S: Treatment of alcoholic cirrhosis with (+)-Cyanidanol-3, in Conn HO (ed): International Workshop on (+)-Cyanidanol-3 in Diseases of the Liver. Royal Society of Medicine, Academic Press, London and Grune and Stratton, New York, 1981, pp. 167–171.Google Scholar
  15. 15.
    Zimmerman HJ, Seeff LB: Enzymes in hepatic disease, in Coodley EL (ed): Diagnostic Enzymology. Philadelphia, Lea & Febiger, 1970, pp. 1–38.Google Scholar
  16. 16.
    Cohen JA, Kaplan MM: The SGOT/SGPT Ratio—An indicator of alcoholic liver disease. Dig Dis Sci 24:835–838, 1979.PubMedCrossRefGoogle Scholar
  17. 17.
    Nalpas B, Vassault A, Charpin S, et al: Serum mitochondrial asparate aminotransferase as a marker of chronic alcoholism: Diagnostic value and interpretation in a liver unit. Hepatology 6:608–614, 1986.PubMedCrossRefGoogle Scholar
  18. 18.
    Orrego H, Kalant H, Israel Y, et al: Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease. Gastroenterology 76:105–115, 1979.PubMedGoogle Scholar
  19. 19.
    Maddrey WC, Boitnott JK, Bedine MS, et al: Adrenocosteroid therapy of alcoholic hepatitis. Gastroenterology 75:193–199, 1978.PubMedGoogle Scholar
  20. 20.
    Maddrey WC, Carithers JR RL, Herlong HF, et al: Prednisolone therapy in patients with severe alcoholic hepatitis. Results of a multicenter trial. Hepatology 6:1202, 1986 (abst).Google Scholar
  21. 21.
    Conn HO: The management of alcoholic hepatitis, in Conn HO (ed): International Workshop on (+)-Cyanidanol-3 in Diseases of the Liver. Royal Society of Medicine, Academic Press, London and Grune and Stratton, New York, 1981, pp. 147–156.Google Scholar
  22. 22.
    Hallak A, Conn HO: Prognostic value of blood tests in alcoholic hepatitis (AH). Analysis of the randomized clinical trials (RCT). (in preparation)Google Scholar
  23. 23.
    Porter HP, Simon FR, Pope CE, et al: Corticosteroid therapy in severe alcoholic hepatitis: A double-blind drug trial. S Engl J Med 284:1350–1355, 1971.CrossRefGoogle Scholar
  24. 24.
    Campra JL, Hamlin EM, Kirshbaum RJ, et al: Prednisone therapy of acute alcoholic hepatitis: Report of a controlled trial. Ann Intern Med 79:625–631, 1973.PubMedGoogle Scholar
  25. 25.
    Blitzer BL, Mutchnick MG, Joshi PH, et al: Adrenocorticosteroid therapy in alcoholic hepatitis: A prospective, double-blind randomized study. Am J Dig Dis 22:477–484, 1977.PubMedCrossRefGoogle Scholar
  26. 26.
    Lesesne HR, Bozymski EM, Fallon HJ: Treatment of alcoholic hepatitis with encephalopathy: Comparison of prednisolone with caloric supplements. Gastroenterology 74:169–173, 1978.PubMedGoogle Scholar
  27. 27.
    Shumaker JB, Resnick RH, Galambos JT, et al: A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. Am J Gastroenterol 69:443–449, 1978.PubMedGoogle Scholar
  28. 28.
    Depew W, Boyer T, Omata M, et al: Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy. Gastroenterology 78:524–529, 1980.PubMedGoogle Scholar
  29. 29.
    Mendenhall CL, Anderson S, Garcia-Pont P, et al: Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. S Engl J Med 23:1464–1470, 1984.CrossRefGoogle Scholar
  30. 30.
    The Copenhagen Study Group for Liver Diseases: Testosterone treatment of men with alcoholic cirrhosis. A double-blind study. Hepatology 6:807–813, 1986.CrossRefGoogle Scholar
  31. 31.
    Nasrallah SM, Galambos JT: Aminoacid therapy of alcoholic hepatitis. Lancet 2:1276–1277, 1980.PubMedCrossRefGoogle Scholar
  32. 32.
    Diehl AM, Boitnott JK, Herlong F, et al: Effect of parenteral amino acid supplementation in alcoholic hepatitis. Hepatology 5:57–63, 1985.PubMedCrossRefGoogle Scholar
  33. 33.
    Baker AL, Jaspan JB, Haines NW, et al: A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: Progress report in 50 patients. Gastroenterology 80:1410–1414, 1981.PubMedGoogle Scholar
  34. 34.
    Halle P, Pare P, Kaptein E, et al: Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis. Gastroenterology 82:925–931, 1982.PubMedGoogle Scholar
  35. 35.
    Resnick RH, Boitnott J, Iber FL, et al: Preliminary observations of d-penicillamine therapy in acute alcoholic liver disease. Digestion 11:257–265, 1974.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1989

Authors and Affiliations

  • Harold O. Conn
    • 1
    • 2
  • R. Hallak
    • 1
    • 2
  1. 1.Yale University School of MedicineUSA
  2. 2.Liver Disease UnitVeterans Administration Medical CenterWest HavenUSA

Personalised recommendations